Cargando…

Drug-resistant Diarrheogenic Escherichia coli, Mexico

Diarrheogenic Escherichia coli isolates from 45 (73%) of 62 hospitalized patients were resistant to common antimicrobial drugs. Sixty-two percent were multidrug resistant, and >70% were resistant to trimethoprim-sulfamethoxazole and ampicillin. Ciprofloxacin and cefotaxime were uniformly active....

Descripción completa

Detalles Bibliográficos
Autores principales: Estrada-García, Teresa, Cerna, Jorge F., Paheco-Gil, Leova, Velázquez, Raúl F., Ochoa, Theresa J., Torres, Javier, DuPont, Herbert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320511/
https://www.ncbi.nlm.nih.gov/pubmed/16102327
http://dx.doi.org/10.3201/eid1108.050192
_version_ 1782228847673999360
author Estrada-García, Teresa
Cerna, Jorge F.
Paheco-Gil, Leova
Velázquez, Raúl F.
Ochoa, Theresa J.
Torres, Javier
DuPont, Herbert L.
author_facet Estrada-García, Teresa
Cerna, Jorge F.
Paheco-Gil, Leova
Velázquez, Raúl F.
Ochoa, Theresa J.
Torres, Javier
DuPont, Herbert L.
author_sort Estrada-García, Teresa
collection PubMed
description Diarrheogenic Escherichia coli isolates from 45 (73%) of 62 hospitalized patients were resistant to common antimicrobial drugs. Sixty-two percent were multidrug resistant, and >70% were resistant to trimethoprim-sulfamethoxazole and ampicillin. Ciprofloxacin and cefotaxime were uniformly active. Effective and safe oral agents are needed to treat children with bacterial diarrhea.
format Online
Article
Text
id pubmed-3320511
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-33205112012-04-11 Drug-resistant Diarrheogenic Escherichia coli, Mexico Estrada-García, Teresa Cerna, Jorge F. Paheco-Gil, Leova Velázquez, Raúl F. Ochoa, Theresa J. Torres, Javier DuPont, Herbert L. Emerg Infect Dis Dispatch Diarrheogenic Escherichia coli isolates from 45 (73%) of 62 hospitalized patients were resistant to common antimicrobial drugs. Sixty-two percent were multidrug resistant, and >70% were resistant to trimethoprim-sulfamethoxazole and ampicillin. Ciprofloxacin and cefotaxime were uniformly active. Effective and safe oral agents are needed to treat children with bacterial diarrhea. Centers for Disease Control and Prevention 2005-08 /pmc/articles/PMC3320511/ /pubmed/16102327 http://dx.doi.org/10.3201/eid1108.050192 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Estrada-García, Teresa
Cerna, Jorge F.
Paheco-Gil, Leova
Velázquez, Raúl F.
Ochoa, Theresa J.
Torres, Javier
DuPont, Herbert L.
Drug-resistant Diarrheogenic Escherichia coli, Mexico
title Drug-resistant Diarrheogenic Escherichia coli, Mexico
title_full Drug-resistant Diarrheogenic Escherichia coli, Mexico
title_fullStr Drug-resistant Diarrheogenic Escherichia coli, Mexico
title_full_unstemmed Drug-resistant Diarrheogenic Escherichia coli, Mexico
title_short Drug-resistant Diarrheogenic Escherichia coli, Mexico
title_sort drug-resistant diarrheogenic escherichia coli, mexico
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320511/
https://www.ncbi.nlm.nih.gov/pubmed/16102327
http://dx.doi.org/10.3201/eid1108.050192
work_keys_str_mv AT estradagarciateresa drugresistantdiarrheogenicescherichiacolimexico
AT cernajorgef drugresistantdiarrheogenicescherichiacolimexico
AT pahecogilleova drugresistantdiarrheogenicescherichiacolimexico
AT velazquezraulf drugresistantdiarrheogenicescherichiacolimexico
AT ochoatheresaj drugresistantdiarrheogenicescherichiacolimexico
AT torresjavier drugresistantdiarrheogenicescherichiacolimexico
AT dupontherbertl drugresistantdiarrheogenicescherichiacolimexico